-80%

Perry W. Buffington – Psychopharmacology 2-Day Conference

Name: Perry W. Buffington - Psychopharmacology 2-Day Conference
Availability: InStock
Rating: 4.62 (6 reviews)

Rated 4.62 out of 5 based on 45 customer ratings

$87.00

[Instant Download] – You will receive instant download access after the purchase

Category: Medical & Health Tags: Perry W. Buffington, Perry W. Buffington - Psychopharmacology 2-Day Conference, Psychopharmacology 2-Day Conference

Description
Reviews (6)

Faculty:: Perry W. Buffington
Duration:: 12 Hours 12 Minutes
Format:: Audio and Video
Copyright:: Sep 14, 2017

Description

Outline

DAY ONE

PSYCHOPHARMACOLOGY

Historical antecedents of modern psychopharmacology
Diagnostic issues
Clarification of terms
Drug metabolism concepts: pharmacokinetics & pharmacodynamics
Drug mechanism of action
Placebo & Nocebo
Pharmacotherapy vs. Pharmacotherapy
Developing highly effective collaborations with prescribers

DEPRESSIVE DISORDERS

Biogenic Amine, Cortisol, Down-Regulation, & Neurotropic Hypotheses
Neurochemistry of depression
Types of anti-depressants
Preventing side effects
Tardive Dysphoria: real or imagined?

ANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERS

Neurochemistry of anxiety
GAD, panic disorders, phobias
OCD
PTSD
Physiological interventions
Anti-anxiety medications
Anti-depressants
Non-pharmacologic options
Benzodiazepines: risks and benefits
Preventing side effects

BIPOLAR DISORDERS

Neurochemistry
The Bipolar Spectrum & DSM-5® Changes
Mood stabilizers
- Lithium
- Anti-convulsants & neuromodulators
Typical, atypical, & third-generation antipsychotics
Effective strategies for improving outcomes for clients

PSYCHOTIC DISORDERS/ SCHIZOPHRENIA

Neurochemistry of psychosis and schizophrenia
Antipsychotic Medications:
- First generation (typical)
- Second generation (atypical)
Managing side effects
- Extrapyramidal symptoms and TD
- Metabolic problems- what blood tests are needed and when
- Preventing Diabetes Mellitus
Recognizing hyperprolactinemia- and why you need to know
Use of atypical antipsychotics for multiple disorders

LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

DAY TWO

ATTENTIONAL DISORDERS

Differential diagnosis
Neurochemistry of ADHD
Treatment controversies
Substance abuse and ADHD
Stimulant medications
Non-stimulant options
Preventing side effects

SUBSTANCE ABUSE DISORDERS

Neurochemistry of addiction
Negative reinforcement & creation of habits
Alcohol
Caffeine
Nicotine
Cannabis
Opiates
PCP & Ketamine
MDMA (Ecstasy)
Energy vs. Chill Drinks
Over-the-counter & herbal psychopharmacology
Addiction treatments
Behavioral addictions

SPECIAL POPULATIONS

Specialized guidelines for geriatric patients
Dementia treatment
Slow vs. rapid metabolizers (genetic polymorphisms)

TREATING CLIENTS PAIN

Acute vs. chronic pain
Alternatives to pharmacology
Pain vs. depression: which comes first?

ETHICS & PSYCHOPHARMACOLOGY

High-risk pharmacology & psychopharmacology
Off-label use of medications
Prescribing for children
Elective psychopharmacology
Marketing of mental illness
Polypharmacy
Informed vs. uninformed consent
Patient & third party pressures
Professional boundaries
Ethics associated with medical errors
Role of placebo

FUTURE TRENDS

Change of mind: preventing vs. managing side effects
Medicalization of normal
Computer assisted devices
New meds, new diagnoses, new theories, new normal
Top 10 Medical Emergencies
Integrating psychotherapy with psychopharmacology

LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

Faculty

Perry W. Buffington, PH.D., MS Related seminars and products: 2

Perry Buffington, Ph.D., M.S., has over 20 years of experience in the medical consulting field and is currently a full-time senior lecturer at the University of Georgia, teaching psychopharmacology at the undergraduate and graduate levels. He is former chairman of the prestigious Florida Psychological Association’s Prescriptive Authority Committee and teaches seminars nationwide on minimizing psychopharmacological errors.

As the author of eight books (currently working on his first psychopharmacology text), his by-line has appeared in hundreds of periodicals including the Saturday Evening Post, USA Today, and Success. He is the former contributing editor for Delta Air Lines’ in-flight magazine, Sky, and served as a syndicated newspaper/web columnist for Universal Press. Additional, he hosted his own radio show, syndicated nationally, by Envison Radio Networks.

Perry’s presentation style is engaging, a blend of education and entertainment; as a result, critics (and especially his students) applaud his ability to make complicated topics understandable and applicable – even useful!!

Speaker Disclosures:

Financial: Perry Buffington is the President of Go-Buff Enterprises, Inc. He is a member of the psychology faculty, Franklin College of Arts & Sciences, The University of Georgia. Dr. Buffington receives a speaking honorarium from PESI, Inc.

Nonfinancial: Perry Buffington has no relevant nonfinancial relationship to disclose.

Salepage: https://catalog.pesi.com//item/psychopharmacology-2day-conference-24536

Archive: https://archive.ph/wip/TqeiF

Delivery Method

– After your purchase, you’ll see a View your orders link which goes to the Downloads page. Here, you can download all the files associated with your order.
– Downloads are available once your payment is confirmed, we’ll also send you a download notification email separate from any transaction notification emails you receive from IMCourse.net.
– Since it is a digital copy, our suggestion is to download and save it to your hard drive. In case the link is broken for any reason, please contact us and we will resend the new download link.
– If you cannot find the download link, please don’t worry about that. We will update and notify you as soon as possible at 8:00 AM – 8:00 PM (UTC+8).

Thank You For Shopping With Us!